US withdrawal from WHO will have significant implications
US withdrawal from WHO will have significant implications | Opinion
Show Caption
Hide Caption
US Senator Sheldon Whitehouse answers questions about the RFK hearing
US Senator Sheldon Whitehouse, in RI to attend a groundbreaking for the REGENT' Seaglider factory, answers questions about the RFK hearing
President Trump withdrew the United States from the World Health Organization, a decision criticized by public and global health scholars.
The U.S. provides significant financial support to the WHO, enabling initiatives like disease eradication and maternal health programs.
Critics argue that withdrawing from the WHO will create a vacuum in global health leadership, potentially benefiting China.
The decision raises concerns about the U.S.'s ability to protect its citizens from future pandemics and influence global health policy.
Global health is a matter of national security, especially in an interconnected world facing shared health challenges.
As part of the sweeping reforms in his first few days in office, President Donald Trump announced he is withdrawing the United States from the World Health Organization. The decision, which has been criticized by public and global health scholars, will have far-reaching consequences ‒ not only globally but also for the health and security of the U.S.
In my global health courses, I often remind my students that infectious diseases know no borders. COVID-19 serves as a recent, devastating reminder of how quickly diseases spread across the globe. According to the Population Reference Bureau, 70,000 foreigners arrive daily in the U.S., mostly visitors, and according to the Federal Aviation Administration (2024), 2.9 million passengers fly every day in and out of U.S. airports ‒ international cooperation is essential to safeguard public health.
Given the rising vaccine hesitancy in the U.S. in the context of COVID-19 vaccination rates, this issue will only intensify in the coming years, which would surely take on a new form under Robert F. Kennedy Jr.'s anti-vaccine leadership in Trump's administration. With the recent poliovirus outbreak in New York State in 2022, the U.S. faces an impending public health crisis, which will only be amplified if global efforts to combat disease and outbreak are weakened.
The executive order justifies this withdrawal, citing alleged mismanagement of COVID-19 by the World Health Organization and claims of disproportionate financial demands on the U.S. The organization, founded in 1948, is a specialized agency of the United Nations. The U.S. government has been actively engaged throughout its founding, providing technical and financial support and participating in its governance structure. A report from KFF, formally known as the Kaiser Family Foundation and a leading independent source for health policy research, cites that the U.S. has contributed annually between $163 million and $816 million, making it one of the largest funders, allowing WHO to achieve initiatives such as disease eradication and maternal health programs, among others.
To be sure, scholars advocating for decolonizing global health are critical of the disproportionate decision-making power high-income countries have on what should get funded and how, in sharp contrast to the lesser decision-making power low- or middle-income countries have that are often at the receiving end of the aid. Scholars have noted that these power dynamics echo colonial histories, where global health efforts historically emerged from colonial powers seeking to circumscribe disease in the colonies and protect their populations. Despite these critiques, the solution is reform, not abandonment.
From a strategic perspective, the decision to withdraw has significant geopolitical implications: Ashish Jha, dean of the Brown University School of Public Health, who served as the White House COVID-19 response coordinator from 2022-2023, has called the decision a 'strategic error,' warning that the decision to withdraw from the WHO would create a vacuum in global leadership, likely to be taken up by China. This could risk the U.S. losing its moral authority and its key influence in shaping global health policy.
As such, the decision to abandon the WHO jeopardizes decades of progress in combating diseases like polio and HIV, undermines our ability to protect U.S. citizens from future pandemics, and excludes the country from being included in global discussions on shaping global health policy. In a world as interconnected as ours, global health should not be seen just as an act of altruism; it is a matter of national security.
Given the unimaginable loss the U.S. suffered from COVID-19, one can hope that countries will collaborate to share resources, information and strategies to address some of the highest-priority global health issues.
Sarah Ahmed is an assistant professor of health sciences and women's and gender studies at Providence College.

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
35 minutes ago
- Yahoo
Why has there been a global surge of new Covid variant NB.1.8.1?
India is the latest country to report a surge in new Covid cases, as the latest variant, NB.1.8.1, spreads across the globe. Cases have now been reported in Asian countries such as Thailand, Indonesia and China, while the UK Health Security Agency recorded the first 13 cases in England last week. But the true numbers are unlikely to be known, given the significant decrease in the number of people testing compared to the figures seen during the global pandemic five years ago. NB.1.8.1 stemmed from the Omicron variant and was first detected in January this year. It has quickly spread across China and Hong Kong, and has now been recorded in several states across the United States and Australia. By late April, NB.1.8.1 comprised about 10.7 per cent of submitted sequences globally, according to the World Health Organization (WHO). This rose from just 2.5 per cent a month before. The WHO declared the NB.1.8.1 strain a 'variant under monitoring' on 23 May, which means scientists believe it could potentially affect the behaviour of the virus. Lara Herrero, a virologist from Griffith University in Australia, suspects that NB.1.8.1 spreads more easily than other variants. 'Using lab-based models, researchers found NB.1.8.1 had the strongest binding affinity to the human ACE2 receptor of several variants tested, suggesting it may infect cells more efficiently than earlier strains,' Dr Herrero wrote last month in The Conversation. Dr Chun Tang, GP at UK private healthcare centre Pall Mall Medical, said: 'NB.1.8.1 isn't too different from the Omicron variant, but it does have some tweaks to its spike protein, which might make it spread a bit more easily or slip past some of our existing immunity. 'That said, early signs suggest it doesn't seem to cause more serious illness, but of course, we're still learning more about it.' 'Its spread has been identified in around 22 countries,' said Dr Naveed Asif, GP at The London General Practice. 'The WHO assesses the additional risk to the global public as currently low, and existing Covid-19 vaccines are considered effective in preventing severe disease.' However, the 'Nimbus' variant, as it has been dubbed, does appear to be more transmissible than previous strains, with notable increases reported in India, Hong Kong, Singapore and Thailand, notes Dr Asif. Common symptoms of Nimbus include a severe sore throat, fatigue, mild cough, fever, muscle aches and congestion. It has also been reported that some patients have experienced gastrointestinal symptoms such as nausea and diarrhoea. Healthcare experts have stressed, however, that there is no evidence that the new strain is more deadly or serious than previous variants, and that current Covid vaccines are expected to remain effective and protect anyone infected from severe illness.
Yahoo
41 minutes ago
- Yahoo
2 new measles cases announced in Colorado: Exposure locations, current number of cases
DENVER (KDVR) — Two new measles cases have been announced in Colorado, this time in El Paso and Arapahoe counties. The Colorado Department of Public Health and Environment said in the El Paso County case, a child under the age of 5 years old has a confirmed case of measles after traveling with family to Ontario, Canada, where there is an ongoing measles outbreak. The child has one dose of the measles, mumps and rubella vaccine, CDPHE said. Measles outbreaks in Michigan and Pennsylvania end, while Texas logs just 4 new cases The second case involves an unvaccinated Arapahoe County adult. The person was at Denver International Airport on Tuesday, May 13, which is during the exposure period from a Turkish Airlines passenger who flew while infectious and landed at DIA. This brings the total number of measles cases to 14 in the state, with Arapahoe, Denver and El Paso counties each having four cases, and Pueblo and Archuleta counties each having one. Here are the possible exposure locations for measles from the newly announced cases. Anyone who was there should monitor for symptoms for 21 days after exposure and avoid public gatherings or high-risk settings. Location Date/time When symptoms may develop Powers Pointe Urgent Care5607 Barnes RoadColorado Springs, CO 80917 Tuesday, June 39:30 a.m. – 12:30 p.m. Through June 24 HCA HealthONE Aurora (Medical Center of Aurora) Emergency Department1501 S. Potomac CO 80012 Thursday, June 54:55 – 10:05 p.m. Through June 26 Safeway1200 S. Buckley RoadAurora, CO 80017 Friday, June 64 – 6:15 p.m. Through June 27 St. Francis Medical Center Emergency Department6001 E. Woodmen RoadColorado Springs, CO 80923 Saturday, June 79:30 – 10:50 a.m. Through June 28 UCHealth University of Colorado Hospital Emergency Department12605 E. 16th CO 80045 Saturday, June 72 – 4:10 p.m. Through June 28 There are further exposure locations in Aurora, Colorado Springs, Denver, Evergreen, Glendale, Grand Junction, Greenwood Village and Windsor. All locations and time frames have been listed on CDPHE's website here. Anyone who was at the above locations during the exposure window and develops symptoms should immediately contact their health provider by phone. If you do not have a provider, call urgent care or an emergency department and explain your measles exposure. Calling ahead helps limit further exposures. Measles vaccination rates drop after COVID-19 pandemic in counties across the US Measles is highly contagious and can spread through the air via coughs and sneezes. The disease can remain in the air up to two hours after the person has left. The best way to protect yourself and your loved ones is through the MMR vaccine, according to CDPHE. Two doses of the MMR vaccination are about 97% effective in preventing measles, CDPHE has repeatedly stated. 'In rare cases, people who are vaccinated can still get measles, but their symptoms are usually milder, and they are less likely to spread it to others,' CDPHE explained in a release. About 93.7% of Colorado children have the MMR vaccination, which protects against measles, mumps, rubella and varicella. That's below the goal threshold of 95% for community immunity. Coloradans can check their own or their child's immunization records through the state's Immunization Information System public portal. If your provider has not reported vaccines, some records may be incomplete. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Yahoo
an hour ago
- Yahoo
Why has there been a global surge of new Covid variant NB.1.8.1?
India is the latest country to report a surge in new Covid cases, as the latest variant, NB.1.8.1, spreads across the globe. Cases have now been reported in Asian countries such as Thailand, Indonesia and China, while the UK Health Security Agency recorded the first 13 cases in England last week. But the true numbers are unlikely to be known, given the significant decrease in the number of people testing compared to the figures seen during the global pandemic five years ago. NB.1.8.1 stemmed from the Omicron variant and was first detected in January this year. It has quickly spread across China and Hong Kong, and has now been recorded in several states across the United States and Australia. By late April, NB.1.8.1 comprised about 10.7 per cent of submitted sequences globally, according to the World Health Organization (WHO). This rose from just 2.5 per cent a month before. The WHO declared the NB.1.8.1 strain a 'variant under monitoring' on 23 May, which means scientists believe it could potentially affect the behaviour of the virus. Lara Herrero, a virologist from Griffith University in Australia, suspects that NB.1.8.1 spreads more easily than other variants. 'Using lab-based models, researchers found NB.1.8.1 had the strongest binding affinity to the human ACE2 receptor of several variants tested, suggesting it may infect cells more efficiently than earlier strains,' Dr Herrero wrote last month in The Conversation. Dr Chun Tang, GP at UK private healthcare centre Pall Mall Medical, said: 'NB.1.8.1 isn't too different from the Omicron variant, but it does have some tweaks to its spike protein, which might make it spread a bit more easily or slip past some of our existing immunity. 'That said, early signs suggest it doesn't seem to cause more serious illness, but of course, we're still learning more about it.' 'Its spread has been identified in around 22 countries,' said Dr Naveed Asif, GP at The London General Practice. 'The WHO assesses the additional risk to the global public as currently low, and existing Covid-19 vaccines are considered effective in preventing severe disease.' However, the 'Nimbus' variant, as it has been dubbed, does appear to be more transmissible than previous strains, with notable increases reported in India, Hong Kong, Singapore and Thailand, notes Dr Asif. Common symptoms of Nimbus include a severe sore throat, fatigue, mild cough, fever, muscle aches and congestion. It has also been reported that some patients have experienced gastrointestinal symptoms such as nausea and diarrhoea. Healthcare experts have stressed, however, that there is no evidence that the new strain is more deadly or serious than previous variants, and that current Covid vaccines are expected to remain effective and protect anyone infected from severe illness.